Thuja Capital
Overview
Thuja Capital is an early-stage venture capital firm specializing in medical product innovations, including therapeutics, medical devices, and digital health solutions. The firm is headquartered in Utrecht, Netherlands, and focuses on companies that develop clinically validated products with demonstrable benefits for both patients and healthcare professionals. Their investment philosophy centers on backing ventures with strong scientific foundations and clear potential for meaningful clinical impact. The firm typically engages from seed through Series B funding rounds, with initial investments ranging from €500,000 to €5 million and additional capital reserved for follow-on participation. Thuja Capital has developed a strong track record of nurturing healthcare startups through critical development milestones, regulatory challenges, and successful market entry strategies. Their portfolio includes numerous companies that have achieved significant clinical validations, regulatory approvals, and commercial partnerships, reinforcing Thuja's position as a value-adding investor in the European healthcare innovation ecosystem. In December 2021, Thuja Capital announced the final close of its Thuja Capital Healthcare Fund III at €76 million. This fund focuses on investing in early-stage companies developing novel therapeutics, medical devices (including digital health), or nutraceuticals based in the Netherlands, Belgium, or Germany. The fund aims to identify early-stage investment opportunities, often at an academic project or spin-off stage, and work actively with management to develop initial preclinical proof of concept and attract follow-on investment rounds, with the goal of realizing meaningful healthcare impact.
Investment Focus
- Early-stage companies developing novel therapeutics, medical devices, or digital health solutions
- Companies based in the Netherlands, Belgium, or Germany
- Strong scientific foundations with potential for meaningful clinical impact
Portfolio Companies
Reach Thuja Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Thuja Capital
What sectors does Thuja Capital invest in?
Thuja Capital invests in Healthcare, Digital Health, Medical Devices, Diagnostics, Therapeutics and Nutraceuticals, and is based in Utrecht, Utrecht, Netherlands. Thuja Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Thuja Capital invest at?
Thuja Capital backs companies at Pre-Seed, Seed, Early Stage, Series A and Series B, writing cheques of 500K - 5M.
Which regions does Thuja Capital invest in?
Thuja Capital invests across Germany, Netherlands and Belgium.
Who are the partners at Thuja Capital?
Team members listed for Thuja Capital include Michel Briejer (Managing Partner) and Eline Beest (Operating Partner).
What companies has Thuja Capital invested in?
Thuja Capital's portfolio includes Alesta Therapeutics, EsoBiotec and Pan Cancer T.
How do I contact Thuja Capital?
Thuja Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
